Vericel Corporation (VCEL) News
Latest headlines that mention VCEL, newest first · each headline opens the original publisher
- Last price
- $41.88
- Day change
- -2.41%
- Next earnings
- 2026-11-05 BMO
VCEL headlines
latest coverageNot much coverage yet. VCEL has appeared in only a few headlines lately; new stories show up here as publishers cover it.
Focused on regenerative therapies for sports medicine and burn care, this biopharma firm reported a notable insider sale in June.
Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.
Image source: The Motley Fool. Thursday, May 7, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
VCEL news alerts
Get an alert by email or push when a new headline mentions VCEL.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.